Back to Search Start Over

Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders

Authors :
Gerard R. Dawson
Alba Viera-Campos
Alejandro de la Torre-Luque
Inge Winter van Rossum
Nic J.A. van der Wee
Jenna Clark
Bernd Sommer
Martien J H Kas
Jose Vivancos
Hugh Marston
Moji Aghajani
Celso Arango
Jose Luis Ayuso-Mateos
Asad Malik
Ilja M.J. Saris
Brenda W. J. H. Penninx
Amy C. Bilderbeck
Maria Teresa Carreras
Covadonga M. Díaz-Caneja
A. Raslescu
Kas lab
Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep
Psychiatry
Amsterdam Neuroscience - Compulsivity, Impulsivity & Attention
APH - Mental Health
Amsterdam Neuroscience - Complex Trait Genetics
APH - Digital Health
Source :
de la Torre-Luque, A, Viera-Campos, A, Bilderbeck, A C, Carreras, M T, Vivancos, J, Diaz-Caneja, C M, Aghajani, M, Saris, I M J, Raslescu, A, Malik, A, Clark, J, Penninx, B W J H, van der Wee, N, Rossum, I W V, Sommer, B, Marston, H, Dawson, G R, Kas, M J, Ayuso-Mateos, J L & Arango, C 2022, ' Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders ', Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 113, 110463 . https://doi.org/10.1016/j.pnpbp.2021.110463, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 113. PERGAMON-ELSEVIER SCIENCE LTD, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 113:110463. PERGAMON-ELSEVIER SCIENCE LTD, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 113:110463. Elsevier Inc., Progress in Neuro-Psychopharmacology & Biological Psychiatry, 113. PERGAMON-ELSEVIER SCIENCE LTD
Publication Year :
2022

Abstract

BACKGROUND: Emotion recognition constitutes a pivotal process of social cognition. It involves decoding social cues (e.g., facial expressions) to maximise social adjustment. Current theoretical models posit the relationship between social withdrawal factors (social disengagement, lack of social interactions and loneliness) and emotion decoding.OBJECTIVE: To investigate the role of social withdrawal in patients with schizophrenia (SZ) or probable Alzheimer's disease (AD), neuropsychiatric conditions associated with social dysfunction.METHODS: A sample of 156 participants was recruited: schizophrenia patients (SZ; n = 53), Alzheimer's disease patients (AD; n = 46), and two age-matched control groups (SZc, n = 29; ADc, n = 28). All participants provided self-report measures of loneliness and social functioning, and completed a facial emotion detection task.RESULTS: Neuropsychiatric patients (both groups) showed poorer performance in detecting both positive and negative emotions compared with their healthy counterparts (p CONCLUSIONS: Our findings help to detail the similarities and differences in social function and facial emotion recognition in two disorders rarely studied in parallel, AD and SZ. Transdiagnostic patterns in these results suggest that social withdrawal is associated with heightened sensitivity to negative emotion expressions, potentially reflecting hypervigilance to social threat. Across the neuropsychiatric groups specifically, this hypervigilance associated with social withdrawal extended to positive emotion expressions, an emotional-cognitive bias that may impact social functioning in people with severe mental illness.

Details

Language :
English
ISSN :
18784216 and 02785846
Database :
OpenAIRE
Journal :
de la Torre-Luque, A, Viera-Campos, A, Bilderbeck, A C, Carreras, M T, Vivancos, J, Diaz-Caneja, C M, Aghajani, M, Saris, I M J, Raslescu, A, Malik, A, Clark, J, Penninx, B W J H, van der Wee, N, Rossum, I W V, Sommer, B, Marston, H, Dawson, G R, Kas, M J, Ayuso-Mateos, J L & Arango, C 2022, ' Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders ', Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 113, 110463 . https://doi.org/10.1016/j.pnpbp.2021.110463, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 113. PERGAMON-ELSEVIER SCIENCE LTD, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 113:110463. PERGAMON-ELSEVIER SCIENCE LTD, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 113:110463. Elsevier Inc., Progress in Neuro-Psychopharmacology & Biological Psychiatry, 113. PERGAMON-ELSEVIER SCIENCE LTD
Accession number :
edsair.doi.dedup.....4e82b94e4923d0297cb3f06852552840
Full Text :
https://doi.org/10.1016/j.pnpbp.2021.110463